Treatment of Acute Pancreatitis

1. Fluid Resuscitation

• Preferred fluid: Lactated Ringer's (LR) solution is preferred over normal saline (NS). Large volumes of NS cause hyperchloremic metabolic acidosis, which activates trypsinogen and worsens acinar cell injury. LR is more physiologic and may provide anti-inflammatory benefits (lower CRP).
• Rate and volume:
  • IAP/APA recommends goal-directed resuscitation at 5–10 mL/kg/h, targeting heart rate <120/min, MAP 65–85 mmHg, urine output >0.5–1 mL/kg/h.
  • ACG recommends 250–500 mL/h.
  • A practical approach: LR at 5–10 mL/kg/h for the first 2 h, then 1.5–3 mL/kg/h for 12–24 h, with an overall goal of 2–4 L over the first 24 h.
• Monitoring: Serial reassessment every 6–8 h with vitals, urine output, hematocrit, BUN, and creatinine every 8–12 h. A rising BUN during hospitalization signals inadequate hydration and is associated with higher in-hospital mortality.
• Caution: Over-aggressive resuscitation carries risks of fluid overload, abdominal compartment syndrome, and increased need for mechanical ventilation. A targeted, goal-directed strategy is now preferred over historically "aggressive" protocols.
• Colloids: Not routinely recommended; may be considered if hematocrit <24% or albumin <2 g/dL.
• If hemodynamically unstable despite fluids: norepinephrine to maintain MAP ≥65 mmHg.

2. Pain Management

• Acetaminophen 1 g IV/PO every 6 h is the recommended first-line analgesic (650 mg q8h if liver disease or severe alcoholism).
• Opioids may be required given the severity of pain. No single opioid is superior. Morphine may theoretically cause sphincter of Oddi spasm, but no clinical evidence shows it worsens pancreatitis — it can be used.
• Low-dose ketamine (0.1–0.3 mg/kg IV) is an opioid-sparing alternative.
• NSAIDs should be avoided in critically ill patients due to the increased risk of acute kidney injury.
• Antiemetics for symptomatic relief of nausea/vomiting.

3. NPO Status and Nutritional Support

• Mild acute pancreatitis: Early oral feeding (as tolerated) is safe and may decrease length of hospitalization. Starting with a soft/low-fat diet when pain is controlled is reasonable.
• Moderate to severe pancreatitis:
  • Early enteral nutrition (EN) via nasal/oral enteric tube with a standard polymeric formula, initiated at a low rate and advanced to goal as fluid resuscitation is completed. This is based on multiple RCTs and meta-analyses demonstrating benefit.
  • EN preserves gut mucosal integrity, prevents bacterial translocation, and may modulate the systemic inflammatory response.
  • Nasogastric vs. nasojejunal: Both routes are acceptable; nasogastric is simpler and equally effective in most patients.
• Parenteral nutrition (TPN): Avoid when possible — associated with more complications than EN. If EN is not feasible, TPN should be instituted no earlier than 7 days after onset of illness.
• Hypertriglyceridemia-induced pancreatitis: In contrast to usual practice, patients should remain fasting for the initial 24–36 h to promote resolution of severe triglyceride elevations. IV insulin to treat hyperglycemia also helps reduce triglycerides.

4. Electrolyte Correction

• Hypocalcemia: Often secondary to hypoalbuminemia — check ionized calcium before replacing. Supplement only if ionized Ca²⁺ is low, QT prolongation is present, or neuromuscular signs (Chvostek/Trousseau) appear. Correct concurrent hypomagnesemia first.
• Hyperglycemia: Results from impaired insulin release and increased gluconeogenesis. May require exogenous insulin, as uncontrolled hyperglycemia worsens inflammation.

5. Antibiotics

• Prophylactic antibiotics are NOT indicated — multiple RCTs and meta-analyses have failed to show they reduce infected necrosis, mortality, or need for surgery.
• When to use antibiotics:
  • Confirmed or suspected infected pancreatic necrosis (fever, leukocytosis, clinical deterioration at ≥2 weeks; gas within necrosis on CT)
  • Extrapancreatic infections: cholangitis, pneumonia, bacteremia, UTI
  • Toxic-appearing patients where sepsis cannot be excluded
• Antibiotic choice for infected necrosis: Must penetrate pancreatic tissue and cover gram-negative organisms, gram-positive organisms, and anaerobes. Carbapenems (meropenem 1 g IV q8h) are preferred. Alternatives: fluoroquinolones + metronidazole, or piperacillin-tazobactam.

6. Severity Assessment and Triage

• No SIRS at 24 h: Unlikely to develop organ failure → regular ward.
• Persistent SIRS or comorbidities: Step-down/monitored unit.
• Organ failure + no response to resuscitation → ICU.

7. Etiology-Specific Interventions

Gallstone Pancreatitis

• ERCP is indicated only in the setting of concurrent cholangitis or biliary obstruction (within 24–48 h of admission). It is not indicated for uncomplicated gallstone pancreatitis.
• Cholecystectomy: Should be performed during the same admission for mild acute pancreatitis to prevent recurrence (laparoscopic cholecystectomy is safe once inflammation resolves). For non-surgical candidates: endoscopic biliary sphincterotomy before discharge.

Hypertriglyceridemia (TG >1000 mg/dL)

• IV insulin infusion (to treat hyperglycemia and reduce triglycerides)
• Extended fasting (24–36 h)
• Adjunctive: heparin or plasmapheresis (insufficient evidence for routine use)

8. Management of Complications

Pancreatic Necrosis

• Sterile necrosis: Managed conservatively — no debridement indicated.
• Infected necrosis:
  • Start appropriate antibiotics (carbapenems preferred).
  • Step-up approach is preferred: begin with CT-guided percutaneous drainage, then progress to endoscopic drainage (endoscopic transluminal debridement via transgastric or transduodenal route — "walled-off necrosis"), and only proceed to surgical necrosectomy if less invasive methods fail.
  • Open surgical necrosectomy is reserved for failure of minimally invasive approaches.
  • Timing: delay intervention for ≥4 weeks if possible to allow necrosis to become walled-off.

Pseudocysts

• Most acute peripancreatic fluid collections resolve spontaneously and require no intervention.
• Pancreatic pseudocysts (>4 weeks, wall-defined) require drainage only if symptomatic (pain, obstruction, infection) — via endoscopic cystogastrostomy/cystoduodenostomy or percutaneous drainage.

Organ Failure

• ARDS/Respiratory failure: Supplemental O₂; mechanical ventilation if needed.
• Renal failure: Fluid resuscitation; renal replacement therapy if severe.
• Cardiovascular support: Vasopressors (norepinephrine) for refractory hypotension.

9. Disposition

• Most patients require hospitalization for IV fluids, monitoring, and pain control.
• Patients with mild disease (BISAP <3, no SIRS, normal BUN/hematocrit, resolving pain) may be managed on a regular ward.
• ICU admission for organ failure, hemodynamic instability, or APACHE II ≥8.

Summary Algorithm

Acute Pancreatitis Diagnosed
         ↓
Fluid resuscitation (LR preferred) + Pain control + NPO initially
         ↓
Risk stratify: BISAP, SIRS, BUN, hematocrit
         ↓
Mild → Early oral feeding → Cholecystectomy (if gallstones) same admission
Moderate-Severe → Enteral nutrition via tube → Monitor closely
         ↓
Fever + worsening at 2+ weeks → CT: Infected necrosis?
         → Yes: Antibiotics (carbapenem) + Step-up drainage
         → No: Continue conservative management
         ↓
Cholangitis/biliary obstruction present? → ERCP within 24-48 h

• Harrison's Principles of Internal Medicine, 22nd Ed. (2025), Chapter 359
• Rosen's Emergency Medicine, 9th Ed., Chapter 77
• Mulholland & Greenfield's Surgery, 7th Ed. (Nutrition in Acute Pancreatitis)
• Beij A, et al. "Acute Pancreatitis: An Update of Evidence-Based Management." United European Gastroenterol J. 2025 Feb [PMID: 39804691]
• IAP/APA Revised Guidelines on Acute Pancreatitis 2025 (PubMed available)